The Vistria Group, a Chicago-based investment firm focusing on the healthcare, education and financial services sectors, has led the recapitalization of and growth investment in Medalogix and Muse Healthcare, two data science and machine learning technology companies focused on the advancement of patient care within home health, palliative and hospice care settings. Medalogix and Muse Healthcare will consolidate under the Medalogix brand to create a new company that leverages each firm’s expertise and technology to improve care quality.
“We are delighted to partner with The Vistria Group, welcome Muse Healthcare to the Medalogix platform, and are excited for LHC Group to join as another minority equity investor as we advance our commitment to provide high quality clinical-decision support to improve healthcare for patients, their families, and their care providers,” said Elliott Wood, president and CEO of Medalogix. “The Vistria Group shares our vision of providing the best possible solutions to our customers and impacting change in healthcare by ensuring patients can be cared for in their home.”
“Integrating our technology with the Medalogix solution platform allows us to cover the entire care continuum for patients in the home, giving our customers the insights and care guidance to obtain the most appropriate outcomes,” said Tom Maxwell, chairman and co-founder of Muse Healthcare. Together, we will accelerate the growth of our customers, ensuring they are using data to support every care decision, and appropriately increase the days of care provided in the place where the patient deserves to be: their home.”
Bryan Mosher, CEO of Muse Healthcare, added, “We are thrilled to join forces with Medalogix and integrate our offerings for our customers. This partnership makes complete sense as both companies are working towards improving the patient experience and obtaining the best outcomes.”
TripleTree and Brentwood Capital served as buyside advisors to Vistria.